Edward B. Leof - Concepedia

Author

Edward B. Leof

Mayo Clinic ORCID

Also Known As

E B Leof, E Leof, E. B. Leof, E. Leof, EDWARD B. LEOF, Edward B Leof, Edward B. Leof, Edward Leof, Edward B. Leof

139

Publications

8.6K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic Vanderbilt University Mayo Clinic in Florida Mayo Clinic in Arizona Pulmonary and Critical Care Associates

About

Edward B. Leof is an author at Mayo Clinic specializing in medicine, cell signaling, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	35	3.8K
2	Cell Biology	27	33	3.7K
3	Cellular Physiology	19	19	1.6K
4	Natural Sciences	6	6	397
5	Biochemistry	1	1	20

Edward B. Leof

Publications

7.6K

Citations

H-Index

Page 1

	Year	Citations
Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity. Edward B. Leof, Jacqueline A. Proper, Anton Scott Goustin, Proceedings of the National Academy of Sciences ThrombopoiesisDevelopmental BiologySignal TransductionCell RegulationBlood Platelet	1986	538
Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosis Craig Daniels, Mark C. Wilkes, Maryanne Edens, Journal of Clinical Investigation	2004	525
Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosis Craig Daniels, Mark C. Wilkes, Maryanne Edens, Journal of Clinical Investigation Antifibrotic TherapyInflammatory Lung DiseaseLung InflammationTyrosine KinasePdgfr Activation	2004	484
Imatinib mesylate blocks a non‐Smad TGF‐β pathway and reduces renal fibrogenesis in vivo Shinong Wang, Mark C. Wilkes, Edward B. Leof, The FASEB Journal Renal PathologyImmunologyRenal InflammationCollagen Type IvRenal Function	2005	461
Suramin inhibition of growth factor receptor binding and mitogenicity in AKR‐2B cells Robert J. Coffey, Edward B. Leof, Gary D. Shipley, Journal of Cellular Physiology	1987	380
Epidermal growth factor (EGF) and somatomedin C regulate G1 progression in competent BALB/c-3T3 cells Edward B. Leof, Walker Wharton, Judson J. Van Wyk, Experimental Cell Research Epidermal Growth FactorDevelopmental BiologyCell ProliferationCell GrowthCompetent Balb/c-3t3 Cells	1982	317
Growth factors and cancer. Anton Scott Goustin, Edward B. Leof, Gary D. Shipley, PubMed	1986	236
Ligand-dependent and -independent Transforming Growth Factor-β Receptor Recycling Regulated by Clathrin-mediated Endocytosis and Rab11 Hugh Mitchell, Amit Choudhury, Richard E. Pagano, Molecular Biology of the Cell Cell GrowthCellular PhysiologyReceptor Tyrosine KinaseEndocytic PathwayFibroblast Growth Factor	2004	217
Transforming Growth Factor-β Activation of Phosphatidylinositol 3-Kinase Is Independent of Smad2 and Smad3 and Regulates Fibroblast Responses via p21-Activated Kinase-2 Mark C. Wilkes, Hugh Mitchell, Sumedha G. Penheiter, Cancer Research	2005	204
Transforming growth factor beta 1 inhibition of p34cdc2 phosphorylation and histone H1 kinase activity is associated with G1/S-phase growth arrest. Philip H. Howe, Giulio Draetta, Edward B. Leof Molecular and Cellular Biology P34cdc2 PhosphorylationP34cdc2 Protein KinaseCell ProliferationG1/s-phase Growth ArrestCell Growth	1991	198

Page 1